Urinary cadmium concentration and the risk of ischemic stroke

Cheng Chen, Pengcheng Xun, Cari Tsinovoi, Leslie A. McClure, John Brockman, Leslie MacDonald, Mary Cushman, Jianwen Cai, Lisa Kamendulis, Jason Mackey, Ka He

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To examine the association between urinary cadmium levels and the incidence of ischemic stroke and to explore possible effect modifications. METHODS: A case-cohort study was designed nested in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, including 680 adjudicated incident cases of ischemic stroke and 2,540 participants in a randomly selected subcohort. Urinary creatinine-corrected cadmium concentration was measured at baseline. Multivariable-adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated with the Barlow weighting method for the Cox proportional hazards regression model. RESULTS: The median urinary cadmium concentration was 0.42 (interquartile range 0.27-0.68) μg/g creatinine. After adjustment for potential confounders, urinary cadmium was associated with increased incidence of ischemic stroke (quintile 5 vs quintile 1: HR 1.50, 95% CI 1.01-2.22, p for trend = 0.02). The observed association was more pronounced among participants in the lowest serum zinc tertile (tertile 3 vs tertile 1: HR 1.82, 95% CI 1.06-3.11, p for trend = 0.004, p for interaction = 0.05) but was attenuated and became nonsignificant among never smokers (tertile 3 vs tertile 1: never smokers: HR 1.27, 95% CI 0.80-2.03, p for trend = 0.29; ever smokers: HR 1.60, 95% CI 1.06-2.43, p for trend = 0.07, p for interaction = 0.51). CONCLUSIONS: Findings from this study suggest that cadmium exposure may be an independent risk factor for ischemic stroke in the US general population. Never smoking and maintaining a high serum zinc level may ameliorate the potential adverse effects of cadmium exposure.

Original languageEnglish (US)
Pages (from-to)e382-e391
JournalNeurology
Volume91
Issue number4
DOIs
StatePublished - Jul 24 2018
Externally publishedYes

Fingerprint

Cadmium
Stroke
Confidence Intervals
Zinc
Creatinine
Incidence
Serum
Proportional Hazards Models
Cohort Studies
Smoking
Population

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Chen, C., Xun, P., Tsinovoi, C., McClure, L. A., Brockman, J., MacDonald, L., ... He, K. (2018). Urinary cadmium concentration and the risk of ischemic stroke. Neurology, 91(4), e382-e391. https://doi.org/10.1212/WNL.0000000000005856

Urinary cadmium concentration and the risk of ischemic stroke. / Chen, Cheng; Xun, Pengcheng; Tsinovoi, Cari; McClure, Leslie A.; Brockman, John; MacDonald, Leslie; Cushman, Mary; Cai, Jianwen; Kamendulis, Lisa; Mackey, Jason; He, Ka.

In: Neurology, Vol. 91, No. 4, 24.07.2018, p. e382-e391.

Research output: Contribution to journalArticle

Chen, C, Xun, P, Tsinovoi, C, McClure, LA, Brockman, J, MacDonald, L, Cushman, M, Cai, J, Kamendulis, L, Mackey, J & He, K 2018, 'Urinary cadmium concentration and the risk of ischemic stroke', Neurology, vol. 91, no. 4, pp. e382-e391. https://doi.org/10.1212/WNL.0000000000005856
Chen C, Xun P, Tsinovoi C, McClure LA, Brockman J, MacDonald L et al. Urinary cadmium concentration and the risk of ischemic stroke. Neurology. 2018 Jul 24;91(4):e382-e391. https://doi.org/10.1212/WNL.0000000000005856
Chen, Cheng ; Xun, Pengcheng ; Tsinovoi, Cari ; McClure, Leslie A. ; Brockman, John ; MacDonald, Leslie ; Cushman, Mary ; Cai, Jianwen ; Kamendulis, Lisa ; Mackey, Jason ; He, Ka. / Urinary cadmium concentration and the risk of ischemic stroke. In: Neurology. 2018 ; Vol. 91, No. 4. pp. e382-e391.
@article{b203c9540f814f73bbee5ed937e239ec,
title = "Urinary cadmium concentration and the risk of ischemic stroke",
abstract = "OBJECTIVES: To examine the association between urinary cadmium levels and the incidence of ischemic stroke and to explore possible effect modifications. METHODS: A case-cohort study was designed nested in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, including 680 adjudicated incident cases of ischemic stroke and 2,540 participants in a randomly selected subcohort. Urinary creatinine-corrected cadmium concentration was measured at baseline. Multivariable-adjusted hazard ratios (HRs) and the corresponding 95{\%} confidence intervals (CIs) were estimated with the Barlow weighting method for the Cox proportional hazards regression model. RESULTS: The median urinary cadmium concentration was 0.42 (interquartile range 0.27-0.68) μg/g creatinine. After adjustment for potential confounders, urinary cadmium was associated with increased incidence of ischemic stroke (quintile 5 vs quintile 1: HR 1.50, 95{\%} CI 1.01-2.22, p for trend = 0.02). The observed association was more pronounced among participants in the lowest serum zinc tertile (tertile 3 vs tertile 1: HR 1.82, 95{\%} CI 1.06-3.11, p for trend = 0.004, p for interaction = 0.05) but was attenuated and became nonsignificant among never smokers (tertile 3 vs tertile 1: never smokers: HR 1.27, 95{\%} CI 0.80-2.03, p for trend = 0.29; ever smokers: HR 1.60, 95{\%} CI 1.06-2.43, p for trend = 0.07, p for interaction = 0.51). CONCLUSIONS: Findings from this study suggest that cadmium exposure may be an independent risk factor for ischemic stroke in the US general population. Never smoking and maintaining a high serum zinc level may ameliorate the potential adverse effects of cadmium exposure.",
author = "Cheng Chen and Pengcheng Xun and Cari Tsinovoi and McClure, {Leslie A.} and John Brockman and Leslie MacDonald and Mary Cushman and Jianwen Cai and Lisa Kamendulis and Jason Mackey and Ka He",
year = "2018",
month = "7",
day = "24",
doi = "10.1212/WNL.0000000000005856",
language = "English (US)",
volume = "91",
pages = "e382--e391",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Urinary cadmium concentration and the risk of ischemic stroke

AU - Chen, Cheng

AU - Xun, Pengcheng

AU - Tsinovoi, Cari

AU - McClure, Leslie A.

AU - Brockman, John

AU - MacDonald, Leslie

AU - Cushman, Mary

AU - Cai, Jianwen

AU - Kamendulis, Lisa

AU - Mackey, Jason

AU - He, Ka

PY - 2018/7/24

Y1 - 2018/7/24

N2 - OBJECTIVES: To examine the association between urinary cadmium levels and the incidence of ischemic stroke and to explore possible effect modifications. METHODS: A case-cohort study was designed nested in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, including 680 adjudicated incident cases of ischemic stroke and 2,540 participants in a randomly selected subcohort. Urinary creatinine-corrected cadmium concentration was measured at baseline. Multivariable-adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated with the Barlow weighting method for the Cox proportional hazards regression model. RESULTS: The median urinary cadmium concentration was 0.42 (interquartile range 0.27-0.68) μg/g creatinine. After adjustment for potential confounders, urinary cadmium was associated with increased incidence of ischemic stroke (quintile 5 vs quintile 1: HR 1.50, 95% CI 1.01-2.22, p for trend = 0.02). The observed association was more pronounced among participants in the lowest serum zinc tertile (tertile 3 vs tertile 1: HR 1.82, 95% CI 1.06-3.11, p for trend = 0.004, p for interaction = 0.05) but was attenuated and became nonsignificant among never smokers (tertile 3 vs tertile 1: never smokers: HR 1.27, 95% CI 0.80-2.03, p for trend = 0.29; ever smokers: HR 1.60, 95% CI 1.06-2.43, p for trend = 0.07, p for interaction = 0.51). CONCLUSIONS: Findings from this study suggest that cadmium exposure may be an independent risk factor for ischemic stroke in the US general population. Never smoking and maintaining a high serum zinc level may ameliorate the potential adverse effects of cadmium exposure.

AB - OBJECTIVES: To examine the association between urinary cadmium levels and the incidence of ischemic stroke and to explore possible effect modifications. METHODS: A case-cohort study was designed nested in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, including 680 adjudicated incident cases of ischemic stroke and 2,540 participants in a randomly selected subcohort. Urinary creatinine-corrected cadmium concentration was measured at baseline. Multivariable-adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated with the Barlow weighting method for the Cox proportional hazards regression model. RESULTS: The median urinary cadmium concentration was 0.42 (interquartile range 0.27-0.68) μg/g creatinine. After adjustment for potential confounders, urinary cadmium was associated with increased incidence of ischemic stroke (quintile 5 vs quintile 1: HR 1.50, 95% CI 1.01-2.22, p for trend = 0.02). The observed association was more pronounced among participants in the lowest serum zinc tertile (tertile 3 vs tertile 1: HR 1.82, 95% CI 1.06-3.11, p for trend = 0.004, p for interaction = 0.05) but was attenuated and became nonsignificant among never smokers (tertile 3 vs tertile 1: never smokers: HR 1.27, 95% CI 0.80-2.03, p for trend = 0.29; ever smokers: HR 1.60, 95% CI 1.06-2.43, p for trend = 0.07, p for interaction = 0.51). CONCLUSIONS: Findings from this study suggest that cadmium exposure may be an independent risk factor for ischemic stroke in the US general population. Never smoking and maintaining a high serum zinc level may ameliorate the potential adverse effects of cadmium exposure.

UR - http://www.scopus.com/inward/record.url?scp=85070483094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070483094&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000005856

DO - 10.1212/WNL.0000000000005856

M3 - Article

C2 - 29934425

AN - SCOPUS:85070483094

VL - 91

SP - e382-e391

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -